Clinical trial
Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic…
NCT00348504 · Abbott, Industry · Completed
Key facts
| NCT number | NCT00348504 |
|---|---|
| Title | Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure. |
| Official title | Survival of Patients With Acute Heart Failure in Need of Intravenous Inotropic Support: a Multicentre, Parallel-Group, Randomised, Double-Blind, Double-Dummy Study of Levosimendan Versus Dobutamine in Patients With Acute Heart Failure. |
| Lead sponsor | Abbott, Industry |
| Collaborators | Orion Corporation, Orion Pharma Industry |
| Status | Completed |
| Phase | Phase 3 |
| Study type | Interventional |
| Conditions | Acute Heart Failure |
| Intervention type | Drug |
| Interventions | levosimendan, dobutamine |
| Enrollment | 1,300 |
| Start date | Mar 1, 2003 |
| Completion | Jun 1, 2005 |
| First posted | Jul 4, 2006 |
| Last update posted | Nov 20, 2007 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: